First Citizens Bank & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

First Citizens Bank & Trust’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$718K	Buy	22,851 +1,967	+9%	+$58.1K	0.01%	378
2026 Q1	$517K	Sell	20,884 -169	-0.8%	-$4.03K	0.01%	430
2025 Q4	$491K	Sell	21,053 -56	-0.3%	-$1.25K	0.01%	448
2025 Q3	$416K	Sell	21,109 -2,577	-11%	-$53K	0.01%	470
2025 Q2	$514K	Buy	+23,686	New	+$559K	0.01%	427

Other funds holding CPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

First Citizens Bank & Trust's CPRX Position: Q2 2026 in Review

First Citizens Bank & Trust increased its Catalyst Pharmaceutical (CPRX) stake by 9.4% in Q2 2026, buying an estimated $58.1K and bringing the position to 22,851 shares worth $718K. The position accounts for 0.01% of the portfolio, ranked #378.

First Citizens Bank & Trust first reported a position in CPRX in Q2 2025 and has held it in 5 quarters since. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

First Citizens Bank & Trust held 22,851 shares of Catalyst Pharmaceutical worth $718K as of Q2 2026.
First Citizens Bank & Trust bought 1,967 Catalyst Pharmaceutical shares in Q2 2026, an estimated $58.1K.
Catalyst Pharmaceutical made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #378 holding.
First Citizens Bank & Trust first reported a position in Catalyst Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.